Mount Sinai Drops Anthem, Sending 200,000 New Yorkers Searching for In-Network Doctors Again

As New York’s health-care titans wage a contractual war, hundreds of thousands of patients are left to foot the bill—underscoring a spreading dysfunction at the heart of American medicine.

On a recent Monday, New York’s gleaming Mount Sinai Hospital saw its seven campuses quietly sever ties with Anthem, the nation’s second-largest health insurer. For some 200,000 New Yorkers, the break felt less quiet: in a city where routine medical care is fraught even in the best of times, thousands suddenly found themselves out-of-network, obliged to cancel appointments or prepare for punitive out-of-pocket costs.

The rupture follows nearly a year of stalled and often public negotiations. Talks broke down definitively in December, when Mount Sinai’s 9,000 physicians were first excluded from Anthem’s network. A narrow reprieve kept the hospitals themselves in network until March, serving as a grace period that evidently failed to yield compromise. On March 6th, just hours after late-night telephone diplomacy collapsed, Mount Sinai shed its remaining Anthem coverage entirely.

The proximate cause, as ever in American health care, is money. Mount Sinai asserts that it is reimbursed up to 35% less by Anthem than by its peer insurers, and says it only asked for a modest, single-digit rate increase. The insurer countered with the familiar script: Mount Sinai, it claims, demanded an average 50% hike—an inflationary binge that would inevitably raise premiums for customers. Both sides dismiss the other’s figures as fantasy.

Beneath the bickering lies a more mundane but consequential irritation: delays and denials of payment. Mount Sinai complains of some $450m in overdue balances and labyrinthine claims procedures, which it sought to address in the new contract. Anthem retorts that the hospital is leveraging patients as bargaining chips to extract carve-outs from basic consumer protections—its own euphemism for claim scrutiny. Somewhere in the sea of recrimination, roughly 8,000 scheduled doctor visits vanished into the ether between January and March.

The city’s battered patients, caught in the crossfire, bear the brunt. In a health system notorious for opacity and surprise bills, they must now scramble to transfer records, find new doctors—or risk hefty charges if they opt to stay with Mount Sinai. For fragile populations, such as those in chronic care regimens or undergoing long-term therapy, the disruption is not merely inconvenient: it is costly and potentially hazardous.

Second-order costs pile up quickly. When hospitals and insurers feud, costs seldom evaporate, but often migrate elsewhere. Patients who delay care may grow sicker, then surface in emergency rooms later at exponentially greater expense. Employers find themselves fielding irate calls from staff whose insurance “networks” disintegrated overnight, straining human resources budgets and workplace morale alike. Even those unaffected may find their premiums creeping upwards to underwrite an ever more adversarial system.

The dispute at Mount Sinai fits an increasingly common pattern. According to KFF Health News, more than 650 U.S. hospitals have had high-profile ructions with insurers since 2021. Confronted with relentless cost inflation—fuelled by staff shortages, wage increases, and a pent-up demand for elective care—hospitals are flexing their negotiating muscles as never before. Yet insurers, themselves under pressure to keep coverage affordable, are growing less pliant. The result: deadlocks that once played out in boardrooms now frequently spill into the public arena, forcing patients to pick sides without clear facts.

For New Yorkers, accustomed to a surfeit of choice, the conflict portends a more precarious future. Mount Sinai is not just another hospital: it anchors a network with specialities ranging from heart transplants to paediatric oncology, serving all boroughs. Anthem, now rebranded as Elevance Health, covers a sizable swathe of the city’s commercial and individual health insurance market. The loss of mutual access threatens once-stable doctor-patient bonds and erodes confidence in the idea that health insurance is, well, insurance.

A national quagmire, with local casualties

Elsewhere, similar contractual brinkmanship has surfaced—though sometimes concluded with midnight deals. In Texas, Memorial Hermann and Blue Cross Blue Shield staved off divorce only after a flurry of legislative threats. In California, public outcry forced Sutter Health and Anthem to the negotiating table after months of stalemate. Such spats reflect not only changing economics but structural flaws unique to the American model, where private negotiation governs the price of nearly every bandage and suture.

Europeans, or even Canadians to the north, will view these paroxysms with a mixture of disbelief and schadenfreude. Their health systems may be bureaucratic and sometimes sluggish, but large swathes of the population are spared the spectacle of hospitals and insurers using patients as pawns in disputes over reimbursement mechanics. In New York, one of the world’s richest cities, thousands of breadwinners lose reliable access to care over the baffling minutiae of claims “editing” and payment cycles.

The public feuds are likely to proliferate. As hospital costs rise—driven by technological investments, ballooning payrolls, and, candidly, managerial ambition—insurers will face pressure to temper premiums that are already the world’s highest. Without some mechanism, legislative or market-driven, to smooth these rival incentives, more patients will find themselves bargaining for their own health anew each January.

We are sympathetic to the logic of market forces and wary of one-size-fits-all regulatory fixes. Still, the present arrangement—whereby the most powerful institutions in American health care treat mutual customers as bargaining chips—seems at best a tepid defense of consumer welfare. The lack of real-time transparency in hospital-insurer squabbles, coupled with the labyrinthine structure of networks, generates more confusion than accountability.

It does not bode well for trust in a system that already ranks last among Western peers for satisfaction and value for money. For New Yorkers, and indeed all Americans, the Mount Sinai-Anthem imbroglio signals not merely a local squall, but a storm cloud edging closer to their own neighborhoods.

Unless the pair resume talks—or lawmakers intervene with rules to protect ongoing care—patients face the real possibility of being left to their own devices amid institutional brinkmanship. In health care, as in politics, gridlock rarely serves the public.

■